Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group
Xcelerate (OTC:XCRT) announced on October 9, 2025 the completed all-cash sale of its majority interest in the ESN Group of companies to Noble Labs Holdings, LLC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xcelerate (OTC:XCRT) announced on October 9, 2025 the completed all-cash sale of its majority interest in the ESN Group of companies to Noble Labs Holdings, LLC.
The company said proceeds from the sale, together with funds from a recent private placement, will be used to refocus on its original mission: implementing an AI-aided medical technology and virtual health care program in Africa through majority-owned AfiyaSasa Africa, LLC, with additional development announcements expected in the near term.
Investors are directed to the company website for ongoing updates.
Positive
- Completed all-cash sale of majority interest in ESN Group
- Proceeds plus recent private placement to fund AfiyaSasa Africa plan
Negative
- No longer retains majority interest in ESN Group
- Future execution depends on proceeds and private placement funding
Details
News Market Reaction – XCRT
On Oct 9, the day this news came out, XCRT closed 6.67% below the previous close.
Data tracked by StockTitan Argus for the Oct 9 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MAULDIN, SC / ACCESS Newswire / October 9, 2025 / Xcelerate, Inc. (OTC Markets:XCRT) today announced the sale of its majority interest in the ESN Group of companies, including ESN Group, Inc. and California Skin Research, Inc to Noble Labs Holdings, LLC, a company that had previously provided funding and marketing support to ESN Group, Inc. The transaction was completed as an all-cash sale.
"We made a decision to divest these assets in order to re-focus our business on our original mission of implementing an AI aided medical technology and virtual health care program in Africa through our majority owned subsidiary, AfiyaSasa Africa, LLC," said Mike O'Shea, Xcelerate's Chief Executive Officer. "Proceeds from this sale, combined with funds raised in a recent private placement, will allow Xcelerate to re-implement this business plan. We anticipate making additional announcements on the development of this business in the near future."
Investors and stakeholders are encouraged to stay updated on the latest developments by visiting the Company's website at https://xcelerate.global.
ABOUT XCELERATE INC.
In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology. For more information visit www.xcelerate.global or contact us at 854-900-2020 or email info@xcelerate.global.
SAFE HARBOR
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.
SOURCE: Xcelerate
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.